Biomedicina y Legislación Sanitaria    
      Grupo de Investigación I+D+i

Act: 01 / 09 / 04  
 
< Comunicaciones a congresos >
 
   
    
 

  Inicio > Publicaciones > Congresos2003-6

 
 

Are genetic mutations in CYP2E1 related with alcoholic acute hepatitis?.

 

 
4th Congress of the European Federation of Internal Medicine
(Berlín, 10-13 de septiembre de 2003)
Autores: Segado A., Santiago C., Herranz ML., Visus E., Solano ML., García-Castaño J., Bañares R., Alvarez E., Bandrés F. y Gomez-Gallego F.
Tipo de comunicación: Panel.
Ámbito del congreso: Interacional.

 

Cytochrome P450 2E1 (CYP2E1) is one of the enzymes involved in the oxidative metabolism of ethanol via the non-alcohol dehydrogenase system through the microsomal ethanol-oxidizing system. It is induced in liver by excessive alcohol consumption, producing high amounts of acetaldehyde in liver cells.

In order to determine whether there is an association between some genetic polymorphisms in CYP2E1 and pathogenesis of alcoholic acute hepatitis (AAH), we investigated the presence of mutations Rsa I and Pst I restriction sites in the 5’ flanking region of CYP2E1 leading to c1 and c2 alleles in the following 90 Spanish patients with liver disease: GROUP 1: Non-alcoholic patients (N=40); GROUP 2: Alcoholic patients without AAH (N=24); GROUP 3: Alcoholic patients with AAH (N=26). Criteria for alcoholism were an ingestion of alcohol higher than 80 g/day during the last 5 years.

DNA were obtained from liver biopsies and mutations were tested by PCR amplification followed by Single Nucleotide Polymorphisms (SNP’s) approach in both regions of CYP2E1.
The investigated mutations were not found in homozygosis. The genotype and allele frequencies of variants c1 and c2 are illustrated in TABLES 1 and 2 respectively.


 

The results show a higher frequency of c2 allele in GROUP 3 than in GROUPS 1 and 2. As c2 allele has been considered to relate to higher enzyme activity in the liver, these preliminary results suggests an important role of CYP2E1 mutations in the development of AAH .

  Table 1
CYP2E1 c1/c1
CYP2E1 c1/c2
  Group 1
0,90
0,10
  Group 2
0,87
0,13
  Group 3
0,46
0,54


  Table 2
CYP2E1c1
CYP2E1c2
  Group 1
0,95
0,05
  Group 2
0,94
0,06
  Group 3
0,73
0,27


 

Work partially supported by grant from the Fundación Mapfre Medicina (2001/2002)
Arriba
27

   
 

   
 
Copyright © 2002-2004, Biolex. Todos los derechos reservados